Showing 471-480 of 8858 results for "".
The Microbiome in Atopic Dermatitis: Where Are We Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-in-atopic-dermatitis-where-are-we-now/23746/It seems increasingly likely that microbes will play a central role in understanding AD and its treatments.The Dermatology and Aesthetics Market: Continued Mergers and Acquisitions Momentum and Emerging Trends
https://practicaldermatology.com/topics/practice-management/the-dermatology-and-aesthetics-market-continued-mergers-and-acquisitions-momentum-and-emerging-trends/23679/The resilience of the dermatology and aesthetics market, coupled with growth opportunities, continues to fuel the M&A trend.Update on the Treatment of Actinic Keratoses
https://practicaldermatology.com/topics/general-topics/update-on-the-treatment-of-actinic-keratoses/21630/From mainstay therapies to newly approved agents, treatment options for actinic keratoses are growing.Study Highlights Top-Rated Dermatology Education Apps
https://practicaldermatology.com/topics/practice-management/study-highlights-top-rated-dermatology-education-apps/23565/Researchers rated apps based on four key features.The Case for JAK Inhibitors to Treat AD
https://practicaldermatology.com/topics/atopic-dermatitis/case-jak-inhibitors-treat-ad/27109/E. James Song, MD, FAAD, Director of Clinical Research and Co-Chief Medical Officer for Frontier Dermatology, discusses his presentation “JAK Inhibitors in Atopic Dermatitis” from the 2024 American Academy of Dermatology (AAD) Innovation Academy.Evolving Perspectives: The Dermatology M&A Market in Today’s Environment
https://practicaldermatology.com/topics/practice-management/evolving-perspectives-the-dermatology-ma-market-in-todays-environment/23945/Halfway through 2023: The trends and emerging insights in the dermatology and aesthetics industries.The Future of Aesthetic Medicine in the US
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-future-of-aesthetic-medicine-in-the-us/23853/A look at five trends shaping the aesthetics market.It is Time to Move Beyond Mushroom Tyrosinase. And Is Hydroquinone What We Think It Is?
https://practicaldermatology.com/topics/pigmentary-disorders/it-is-time-to-move-beyond-mushroom-tyrosinase-and-is-hydroquinone-what-we-think-it-is/23768/New research is offering better clinical clues about the action of tyrosinase inhibitors.Late-Stage Drugs for Atopic Dermatitis: An Update
https://practicaldermatology.com/topics/atopic-dermatitis/late-stage-drugs-for-atopic-dermatitis-an-update/23373/Here’s a look at investigational agents for this common disease.Aesthetic Products Coming Soon: A Global Update
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetic-products-coming-soon-a-global-update/22073/A look at injectable aesthetics on the horizon.